Mackenzie Financial
INDV icon

Mackenzie Financial’s Indivior Pharmaceuticals INDV Stock Holding History

Mackenzie Financial’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Buy
+6,682
New +$242K ﹤0.01% 1435
2025
Q4 		– Sell
-10,456
Closed -$252K – 1744
2025
Q3 		$252K Buy
+10,456
New +$219K ﹤0.01% 1472
2024
Q3 		– Sell
-497,555
Closed -$7.8M – 1632
2024
Q2 		$7.8M Sell
497,555
-57,185
-10% -$1.03M 0.01% 474
2024
Q1 		$11.9M Buy
554,740
+4,100
+0.7% +$77K 0.02% 413
2023
Q4 		$8.31M Sell
550,640
-11,955
-2% -$212K 0.01% 462
2023
Q3 		$11.3M Buy
562,595
+1,909
+0.3% +$43.5K 0.02% 409
2023
Q2 		$12.8M Buy
+560,686
New +$12.9M 0.02% 407

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mackenzie Financial's INDV Position: Q2 2026 in Review

Mackenzie Financial opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 6,682 shares worth $274K. The stake represents ﹤0.01% of the portfolio and ranks #1435 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in INDV as recently as Q3 2025.

Mackenzie Financial first reported a position in INDV in Q2 2023 and has held it in 7 quarters since. The position peaked at $12.8M in Q2 2023. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Mackenzie Financial held 6,682 shares of Indivior Pharmaceuticals worth $274K as of Q2 2026.
  • Indivior Pharmaceuticals was a new Mackenzie Financial position in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1435 holding.
  • Mackenzie Financial first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
  • Mackenzie Financial's Indivior Pharmaceuticals position peaked at $12.8M in Q2 2023.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.